232 related articles for article (PubMed ID: 7018670)
1. Activity of 4'-(9-acridinylamino)methanesulfon-m-anisidide against Chinese hamster cells in multicellular spheroids.
Wilson WR; Whitmore GF; Hill RP
Cancer Res; 1981 Jul; 41(7):2817-22. PubMed ID: 7018670
[TBL] [Abstract][Full Text] [Related]
2. Toxicity of 4'-(9-acridinylamino)methanesulfon-m-anisidide in exponential- and plateau-phase Chinese hamster cell cultures.
Wilson WR; Giesbrecht JL; Hill RP; Whitmore GF
Cancer Res; 1981 Jul; 41(7):2809-16. PubMed ID: 6894713
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the mutagenic and clastogenic activity of amsacrine and other DNA-intercalating drugs in cultured V79 Chinese hamster cells.
Wilson WR; Harris NM; Ferguson LR
Cancer Res; 1984 Oct; 44(10):4420-31. PubMed ID: 6547875
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of resistance of noncycling mammalian cells to 4'-(9-acridinylamino)methanesulfon-m-anisidide: comparison of uptake, metabolism, and DNA breakage in log- and plateau-phase Chinese hamster fibroblast cell cultures.
Robbie MA; Baguley BC; Denny WA; Gavin JB; Wilson WR
Cancer Res; 1988 Jan; 48(2):310-9. PubMed ID: 2825971
[TBL] [Abstract][Full Text] [Related]
5. Cell-cycle-stage specificity of 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA) and interaction with ionizing radiation in mammalian cell cultures.
Wilson WR; Whitmore GF
Radiat Res; 1981 Jul; 87(1):121-36. PubMed ID: 7019954
[No Abstract] [Full Text] [Related]
6. Effects of amsacrine and other DNA-intercalating drugs on nuclear and nucleolar structure in cultured V79 Chinese hamster cells and PtK2 rat kangaroo cells.
Jensen CG; Wilson WR; Bleumink AR
Cancer Res; 1985 Feb; 45(2):717-25. PubMed ID: 3838148
[TBL] [Abstract][Full Text] [Related]
7. Drug sensitivity and cross-resistance of the 4'-(9-acridinylamino)methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia.
Odaimi M; Andersson BS; McCredie KB; Beran M
Cancer Res; 1986 Jul; 46(7):3330-3. PubMed ID: 3754787
[TBL] [Abstract][Full Text] [Related]
8. Topoisomerase II-mediated DNA damage produced by 4'-(9-acridinylamino)methanesulfon-m-anisidide and related acridines in L1210 cells and isolated nuclei: relation to cytotoxicity.
Covey JM; Kohn KW; Kerrigan D; Tilchen EJ; Pommier Y
Cancer Res; 1988 Feb; 48(4):860-5. PubMed ID: 2827887
[TBL] [Abstract][Full Text] [Related]
9. Phase I evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) by a weekly iv dose schedule.
Woodcock TM; Schneider RJ; Young CW
Cancer Treat Rep; 1980 Jan; 64(1):53-5. PubMed ID: 6892893
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of adriamycin in MGH-U1 cells grown as monolayer cultures, spheroids, and xenografts in immune-deprived mice.
Erlichman C; Vidgen D
Cancer Res; 1984 Nov; 44(11):5369-75. PubMed ID: 6488191
[TBL] [Abstract][Full Text] [Related]
11. In vitro chemosensitivities of human tumor stem cells to the Phase II drug 4'-(9-acridinylamino)methanesulfon-m-anisidide and prospective in vivo correlations.
Ahmann FR; Meyskens FL; Moon TE; Durie BG; Salmon SE
Cancer Res; 1982 Nov; 42(11):4495-8. PubMed ID: 6897012
[TBL] [Abstract][Full Text] [Related]
12. Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors.
Pommier Y; Schwartz RE; Zwelling LA; Kerrigan D; Mattern MR; Charcosset JY; Jacquemin-Sablon A; Kohn KW
Cancer Res; 1986 Feb; 46(2):611-6. PubMed ID: 3000581
[TBL] [Abstract][Full Text] [Related]
13. Lethal activity and kinetic response of cultured human cells to 4'-(9-acridinylamino)methanesulfon-m-anisidine.
Drewinko B; Yang LY; Barlogie B
Cancer Res; 1982 Jan; 42(1):107-11. PubMed ID: 6895609
[TBL] [Abstract][Full Text] [Related]
14. Recovery from potentially lethal damage and recruitment time of noncycling clonogenic cells in 9L confluent monolayers and spheroids.
Rodriguez A; Alpen EL; Mendonca M; DeGuzman RJ
Radiat Res; 1988 Jun; 114(3):515-27. PubMed ID: 3375440
[TBL] [Abstract][Full Text] [Related]
15. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells.
de Jong S; Kooistra AJ; de Vries EG; Mulder NH; Zijlstra JG
Cancer Res; 1993 Mar; 53(5):1064-71. PubMed ID: 8382551
[TBL] [Abstract][Full Text] [Related]
16. Comparison of DNA-protein cross-links induced by 4'-(9-acridinylamino)-methanesulfon-m-anisidide and by gamma-radiation.
Chiu SM; Xue LY; Friedman LR; Oleinick NL
Cancer Res; 1989 Feb; 49(4):910-4. PubMed ID: 2912561
[TBL] [Abstract][Full Text] [Related]
17. Cell fusion studies to examine the mechanism for etoposide resistance in Chinese hamster V79 spheroids.
Luo C; Johnston PJ; MacPhail SH; Banáth JP; Oloumi A; Olive PL
Exp Cell Res; 1998 Sep; 243(2):282-9. PubMed ID: 9743588
[TBL] [Abstract][Full Text] [Related]
18. Abrogation of taxol-induced G2-M arrest and apoptosis in human ovarian cancer cells grown as multicellular tumor spheroids.
Frankel A; Buckman R; Kerbel RS
Cancer Res; 1997 Jun; 57(12):2388-93. PubMed ID: 9192815
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of 4'-(9-acridinylamino)methanesulfon-m-anisidide by rat liver microsomes.
Shoemaker DD; Cysyk RL; Gormley PE; DeSouza JJ; Malspeis L
Cancer Res; 1984 May; 44(5):1939-45. PubMed ID: 6546898
[TBL] [Abstract][Full Text] [Related]
20. Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.
Legha SS; Hall SW; Powell KC; Burgess MA; Benjamin RS; Gutterman JU; Bodey GP
Cancer Clin Trials; 1980; 3(2):111-4. PubMed ID: 6893573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
